US/UK/Canada

Share

Pick a time period -
Tags ( Active)

UTA physicists devise gene therapy delivery platform that offers hope for macular degeneration sufferers

The number of macular degeneration sufferers worldwide is projected to reach 288 million by 2040.Millions of adults over age 50 struggle each year with vision loss caused by damage to the retina or common macular degeneration. Physics researchers at The University of Texas at Arlington have developed a new platform that uses ultrafast near-infrared lasers to deliver gene therapy to damaged areas of the retina to enable vision restoration in patients with photo-degenerative diseases. “Most therapies focus on slowing down or halting degeneration but cannot target already-damaged areas

UT Arlington nanoparticles could provide easier route for cell therapy

New process to help patients with cancer, genetic conditions, neurological disordersUT Arlington physics researchers may have developed a way to use laser technology to deliver drug and gene therapy at the cellular level without damaging surrounding tissue. The method eventually could help patients suffering from genetic conditions, cancers and neurological diseases. In a study published recently by the journal Nature Scientific Reports , the team paired crystalline magnetic carbon nanoparticles and continuous wave

NIH funds UT Arlington researchers using light to control and monitor neural activity

University of Texas at Arlington researchers are exploring a better method for initiating certain gene therapies that could better fight the sight-deteriorating disease retinitis pigmentosa. The National Institutes of Health is funding the research. Samarendra Mohanty, assistant professor of physics, expects to receive a total of $384,269 over the next two years from the NIH’s National Institute of Neurological Disorders and Stroke. His work involves using a near-infrared ultrafast laser beam to deliver genes that allow expression of light-sensitive proteins, called opsins, in

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Media